Product Categories
| Country: | China |
|---|---|
| Tel: | 021-65675885 |
| Mobile: | +8618964387627 |
| E-mail: | customer_service@efebio.com |
| QQ: | 3012643761 |
| Skype: | Chat Now! |
| Product Name | MF | CAS | Details |
|---|
| Hopeaphenol | C56H42O12 | 388582-37-4 | Details |
| GW297361 | C16H12N4O3S2 | 388627-21-2 | Details |
| IW-927 | C22H23N3O3S2 | 389142-48-7 | Details |
| 1H-Isoindole-1,3(2H)-dione, 4-(2-aminoethoxy)-2-(2,6-dioxo-3-piperidinyl)- | C15H15N3O5 | 390367-50-7 | Details |
| Spliceostatin A | C28H43NO8 | 391611-36-2 | Details |
| VU0080241 | C19H23N5 | 393845-24-4 | Details |
| EBV lytic cycle inducer-1 | C14H12BrN3O | 394668-43-0 | Details |
| GSK-3/CDK5/CDK2-IN-1 | C21H22N4O2 | 395074-72-3 | Details |
| Aselizumab | 395639-53-9 | Details |
| Picumast | C25H29ClN2O3 | 39577-19-0 | Details |
| Esprolol | C17H27NO4 | 396654-09-4 | Details |
| GLP-1R modulator C5 | C24H21NO3 | 421578-93-0 | Details |
| Corrector C4 | C21H17ClN4O2S2 | 421580-53-2 | Details |
| 2′,3′-Di-O-acetylguanosine | C14H17N5O7 | 42167-65-7 | Details |
| (-)-Phaselic acid | C13H12O8 | 423170-79-0 | Details |
| CTX-0124143 | C17H13FN2O3S | 423731-64-0 | Details |
| CCG-13514 | C25H25BrN2O2 | 423741-32-6 | Details |
| TPA-023B | C21H15F2N5O | 425377-76-0 | Details |
| Glycerophosphoinositol choline | C14H32NO12P | 425642-32-6 | Details |
| Glycerophosphoinositol lysine | C15H33N2O13P | 425642-33-7 | Details |
| 1-(2-fluorophenyl)-3-[5-(2-methoxyphenyl) | C16H13FN4O2S | 426242-86-6 | Details |
| Certolizumab pegol | C24H22F3N | 428863-50-7 | Details |
| EB1 | C18H14N4 | 42951-68-8 | Details |
| Fluenetil | C16H15FO2 | 4301-50-2 | Details |
| MMRi64 | C22H17Cl2N3O | 430458-66-5 | Details |
| AMPK activator 12 | C23H24BrNO2 | 431920-24-0 | Details |
| WAY-639889 | C25H27N5O | 432506-24-6 | Details |
| Lecozotan HCl | C28H29N5O3.ClH | 433282-68-9 | Details |
| Atecegatran TFA | C21H21ClF2N4O4.C2HF3O2 | 433937-75-8 | Details |
| beta-Thujaplicinol | 4356-35-8 | Details |
| Nortopixantrone HCl | C20H26Cl2N6O2 | 438244-41-8 | Details |
| CP-810123 | C14H18N4O | 439608-12-5 | Details |
| DDRI-18 | C26H20N6 | 4402-18-0 | Details |
| PIH | C20H19N5S | 441742-93-4 | Details |
| FK-330 | C29H28ClF3N6O4 | 442198-67-6 | Details |
| ABT-510 acetate | C48H87N13O13 | 442526-87-6 | Details |
| CK2α-IN-1 | C16H11N3O4S | 443747-52-2 | Details |
| SCH-336 | C23H25NO8S3 | 447459-51-0 | Details |
| Topoisomerase II inhibitor 13 | C22H23N9 | 451515-89-2 | Details |
| BMS-488043 | C22H22N4O5 | 452296-83-2 | Details |
| AZD6538 | C15H6FN5O | 453566-30-8 | Details |
| TSPO ligand-1 | C16H10ClNO2 | 4560-08-1 | Details |
| ONO-8713 | C25H24F3NO6S | 459411-08-6 | Details |
| AVP-13358 | C30H29N5O2 | 459805-03-9 | Details |
| Aplaviroc hydrochloride | C33H43N3O6.ClH | 461023-63-2 | Details |
| IDO1/TDO-IN-4 | C14H10N4 | 461424-21-5 | Details |
| N-benzoyl-L-aspartic acid | C11H11NO5 | 4631-12-3 | Details |
| Elsilimomab | 468715-71-1 | Details |
| 1M6 | C9H6N2O5 | 4693-01-0 | Details |
| GW438014A | C23H23N3O4S | 469861-49-2 | Details |
| IFB-088 acetate | C10H13ClN4O2 | 469866-31-7 | Details |
| 5MPN | C15H19N3O4 | 47208-82-2 | Details |
| Carpinontriol B | C19H20O6 | 473451-73-9 | Details |
| LSD1-IN-24 | C18H20N2OS | 4734-59-2 | Details |
| MM0299 | C26H23NO5 | 474255-10-2 | Details |
| Fmoc-MMAE | C54H77N5O9 | 474645-26-6 | Details |
| Musellarin A | C20H20O4 | 477565-36-9 | Details |
| GGTI-2154 hydrochloride | 478908-50-8 | Details |
| IK-862 | C25H27N3O4 | 478911-60-3 | Details |
| broparestrol | C22H19Br | 479-68-5 | Details |
| Diaplasinin | C32H31N5O | 481631-45-2 | Details |
| Denagliptin | C20H18F3N3O | 483369-58-0 | Details |
| β-Glucuronidase-IN-1 | C23H27N3O3S | 484006-66-8 | Details |
| FAK-IN-10 | C15H10BrN3O2S | 491839-65-7 | Details |
| PDCD4-IN-1 | C12H9BrClN3O | 494763-64-3 | Details |
| Penflufen | C18H24FN3O | 494793-67-8 | Details |
| Egis-11150 | C19H21ClFN5O2 | 494861-87-9 | Details |
| Androstane-3,6,17-triol | C19H32O3 | 49644-04-4 | Details |
| Drupacine | C18H21NO5 | 49686-57-9 | Details |
| Pritumumab | 499212-74-7 | Details |
| Picarbutrazox | C20H23N7O3 | 500207-04-5 | Details |
| 2-benzylsulfanyl-6-methoxy-4-methylquinazoline | C17H16N2OS | 500272-00-4 | Details |
| MK-0873 | C25H18N4O3 | 500355-52-2 | Details |
| Quorum Sensing-IN-3 | C14H10N2OS | 5005-14-1 | Details |
| NSC61610 | C34H24N6O2 | 500538-94-3 | Details |
| Delmitide acetate | C61H109N17O13 | 501019-16-5 | Details |
| N-[(4-methylphenyl)carbamothioyl]-2-nitrobenzamide | C15H13N3O3S | 501105-47-1 | Details |
| TIE-2/VEGFR-2 kinase-IN-2 | C20H13F4N5O2 | 501693-48-7 | Details |
| 23-epi-26-Deoxyactein | C37H56O10 | 501938-01-8 | Details |
| Cantuzumab mertansine | 400010-39-1 | Details |
| Erucifoline | C18H23NO6 | 40158-95-0 | Details |
| Celivarone | C34H47NO4 | 401925-43-7 | Details |
| WAY-297848 | C13H13ClN2O2S | 404360-27-6 | Details |
| Flurocitabine HCl | C9H11ClFN3O4 | 40505-45-1 | Details |
| Bufotenidine hydrochloride(487-91-2 Free base) | C13H19ClN2O | 40581-89-3 | Details |
| GW6340 | C33H32ClF3N2O2 | 405910-78-3 | Details |
| BCAT-IN-4 | C19H14N2O4S | 406190-85-0 | Details |
| ANO1-IN-1 | C18H28N2O2S | 407587-01-3 | Details |
| Flucetosulfuron | C18H22FN5O8S | 412928-75-7 | Details |
| Goxalapladib | C40H39F5N4O3 | 412950-27-7 | Details |
| ESP-31015 | C17H34O3 | 413624-55-2 | Details |
| Bleomycin A2 | C55H85N17O25S4 | 41432-97-7 | Details |
| RDR 02308 | C19H15N3O3 | 4155-82-2 | Details |
| GPR30 agonist-1 | C19H17BrFNO | 415919-74-3 | Details |
| LM-1685 | C18H16ClNO4S | 416901-58-1 | Details |
| Transketolase-IN-4 | C19H14ClN3O | 419547-73-2 | Details |
| Nafetolol | C19H29NO3 | 42050-23-7 | Details |
| Amorphigenin | C23H22O7 | 4208-09-7 | Details |
| Etilefrine pivalate HCl | C15H24ClNO3 | 42145-91-5 | Details |
| p38 MAP Kinase Inhibitor Ⅵ | C16H13FN2OS2 | 421578-46-3 | Details |
| Product Total： Product Page： | ||||
| 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 | ||||